메뉴 건너뛰기




Volumn 53, Issue 3, 2012, Pages 139-148

Benign prostatic hyperplasia: From bench to clinic

Author keywords

Etiology; Lower urinary tract symptoms; Prostatic hyperplasia; Therapy

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROGEN RECEPTOR; AROMATASE INHIBITOR; DOXAZOSIN; DUTASTERIDE; EPIDERMAL GROWTH FACTOR; FINASTERIDE; INSULIN; NAFTOPIDIL; PHOSPHODIESTERASE V INHIBITOR; SABAL EXTRACT; SILDENAFIL; SILODOSIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TADALAFIL; TAMSULOSIN; TERAZOSIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VARDENAFIL;

EID: 84930478407     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2012.53.3.139     Document Type: Article
Times cited : (51)

References (92)
  • 1
    • 0021149603 scopus 로고
    • The development of human benign prostatic hyperplasia with age
    • Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132: 474-9.
    • (1984) J Urol , vol.132 , pp. 474-479
    • Berry, S.J.1    Coffey, D.S.2    Walsh, P.C.3    Ewing, L.L.4
  • 2
    • 33645956542 scopus 로고    scopus 로고
    • BPH: Epidemiology and comorbidities
    • McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006;12(5 Suppl):S122-S128.
    • (2006) Am J Manag Care , vol.12 , Issue.5 SUPPL.
    • McVary, K.T.1
  • 4
    • 34447102992 scopus 로고    scopus 로고
    • Modifiable risk factors for benign prostatic hyper-plasia and lower urinary tract symptoms: New approaches to old problems
    • Parsons JK. Modifiable risk factors for benign prostatic hyper-plasia and lower urinary tract symptoms: new approaches to old problems. J Urol 2007;178:395-401.
    • (2007) J Urol , vol.178 , pp. 395-401
    • Parsons, J.K.1
  • 5
    • 0028579473 scopus 로고
    • Syndrome X: 6 years later
    • Reaven GM. Syndrome X: 6 years later. J Intern Med Suppl 1994;736:13-22.
    • (1994) J Intern Med Suppl , vol.736 , pp. 13-22
    • Reaven, G.M.1
  • 6
    • 0026021161 scopus 로고
    • Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipi-demia, and atherosclerotic cardiovascular disease
    • DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipi-demia, and atherosclerotic cardiovascular disease. Diabetes care 1991;14:173-94.
    • (1991) Diabetes Care , vol.14 , pp. 173-194
    • Defronzo, R.A.1    Ferrannini, E.2
  • 7
    • 66749185880 scopus 로고    scopus 로고
    • Clinical review: Prevalence and incidence of endocrine and meta-bolic disorders in the United States: A comprehensive review
    • Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: prevalence and incidence of endocrine and meta-bolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009;94:1853-78.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 1853-1878
    • Golden, S.H.1    Robinson, K.A.2    Saldanha, I.3    Anton, B.4    Ladenson, P.W.5
  • 8
    • 0035108041 scopus 로고    scopus 로고
    • Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia
    • Hammarsten J, Högstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001;39: 151-8.
    • (2001) Eur Urol , vol.39 , pp. 151-158
    • Hammarsten, J.1    Högstedt, B.2
  • 10
    • 26644462647 scopus 로고    scopus 로고
    • Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer
    • Ochiai A, Fritsche HA, Babaian RJ. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Urology 2005;66:819-23.
    • (2005) Urology , vol.66 , pp. 819-823
    • Ochiai, A.1    Fritsche, H.A.2    Babaian, R.J.3
  • 12
    • 33751414540 scopus 로고    scopus 로고
    • The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia
    • Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 2007;51:199-203.
    • (2007) Eur Urol , vol.51 , pp. 199-203
    • Ozden, C.1    Ozdal, O.L.2    Urgancioglu, G.3    Koyuncu, H.4    Gokkaya, S.5    Memis, A.6
  • 13
    • 72849125103 scopus 로고    scopus 로고
    • Increased cell proliferation and contractility of prostate in insulin resistant rats: Linking hyperinsulinemia with benign prostate hyperplasia
    • Vikram A, Jena GB, Ramarao P. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia. Prostate 2010;70: 79-89.
    • (2010) Prostate , vol.70 , pp. 79-89
    • Vikram, A.1    Jena, G.B.2    Ramarao, P.3
  • 14
    • 0032559272 scopus 로고    scopus 로고
    • Plasma insulin-like growth factor-I and pros-tate cancer risk: A prospective study
    • Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, et al. Plasma insulin-like growth factor-I and pros-tate cancer risk: a prospective study. Science 1998;279:563-6.
    • (1998) Science , vol.279 , pp. 563-566
    • Chan, J.M.1    Stampfer, M.J.2    Giovannucci, E.3    Gann, P.H.4    Ma, J.5    Wilkinson, P.6
  • 15
    • 0036852701 scopus 로고    scopus 로고
    • Prostate cancer: Another aspect of the insulin-resistance syndrome?
    • Barnard RJ, Aronson WJ, Tymchuk CN, Ngo TH. Prostate cancer: another aspect of the insulin-resistance syndrome? Obes Rev 2002;3:303-8.
    • (2002) Obes Rev , vol.3 , pp. 303-308
    • Barnard, R.J.1    Aronson, W.J.2    Tymchuk, C.N.3    Ngo, T.H.4
  • 16
    • 0022856921 scopus 로고
    • Diet, obesity and hypertension: An hypothesis in-volving insulin, the sympathetic nervous system, and adaptive thermogenesis
    • Landsberg L. Diet, obesity and hypertension: an hypothesis in-volving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986;61:1081-90.
    • (1986) Q J Med , vol.61 , pp. 1081-1090
    • Landsberg, L.1
  • 18
    • 33644832359 scopus 로고    scopus 로고
    • Lower urinary tract symptoms and sexual dysfunction: Epidemiology and pathophysiology
    • McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 2006;97(Suppl2):23-8.
    • (2006) BJU Int , vol.97 , Issue.2 SUPPL. , pp. 23-28
    • McVary, K.1
  • 19
    • 0037143638 scopus 로고    scopus 로고
    • A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis
    • Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-9.
    • (2002) Circulation , vol.106 , pp. 913-919
    • Verma, S.1    Wang, C.H.2    Li, S.H.3    Dumont, A.S.4    Fedak, P.W.5    Badiwala, M.V.6
  • 20
    • 41649119115 scopus 로고    scopus 로고
    • Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial
    • Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, et al. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidermiol 2008;167:925-34.
    • (2008) Am J Epidermiol , vol.167 , pp. 925-934
    • Kristal, A.R.1    Arnold, K.B.2    Schenk, J.M.3    Neuhouser, M.L.4    Goodman, P.5    Penson, D.F.6
  • 22
    • 42749095533 scopus 로고    scopus 로고
    • Physical activity, benign prostatic hyper plasia, and lower urinary tract symptoms
    • Parsons JK, Kashefi C. Physical activity, benign prostatic hyper plasia, and lower urinary tract symptoms. Eur Urol 2008;53: 1228-35.
    • (2008) Eur Urol , vol.53 , pp. 1228-1235
    • Parsons, J.K.1    Kashefi, C.2
  • 24
    • 69949102770 scopus 로고    scopus 로고
    • Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia
    • Parsons JK, Im R. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia. J Urol 2009;182: 1463-8.
    • (2009) J Urol , vol.182 , pp. 1463-1468
    • Parsons, J.K.1    Im, R.2
  • 25
    • 34547677616 scopus 로고    scopus 로고
    • Examination of the relationship between symptoms of prostatitis and histological inflammation: Baseline data from the REDUCE chemoprevention trial
    • Nickel JC, Roehrborn CG, O'leary MP, Bostwick DG, Somerville MC, Rittmaster RS. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J Urol 2007;178: 896-900.
    • (2007) J Urol , vol.178 , pp. 896-900
    • Nickel, J.C.1    Roehrborn, C.G.2    O'Leary, M.P.3    Bostwick, D.G.4    Somerville, M.C.5    Rittmaster, R.S.6
  • 26
    • 55749103206 scopus 로고    scopus 로고
    • The relationship between prostate inflame mation and lower urinary tract symptoms: Examination of baseline data from the REDUCE trial
    • Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS. The relationship between prostate inflame mation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 2008;54:1379-84.
    • (2008) Eur Urol , vol.54 , pp. 1379-1384
    • Nickel, J.C.1    Roehrborn, C.G.2    O'Leary, M.P.3    Bostwick, D.G.4    Somerville, M.C.5    Rittmaster, R.S.6
  • 27
    • 0037326098 scopus 로고    scopus 로고
    • Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis
    • Di Silverio F, Gentile V, De Matteis A, Mariotti G, Giuseppe V, Luigi PA, et al. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol 2003;43: 164-75.
    • (2003) Eur Urol , vol.43 , pp. 164-175
    • di Silverio, F.1    Gentile, V.2    de Matteis, A.3    Mariotti, G.4    Giuseppe, V.5    Luigi, P.A.6
  • 28
    • 77249147858 scopus 로고    scopus 로고
    • Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial
    • Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, et al. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidermiol 2010;171: 571-82.
    • (2010) Am J Epidermiol , vol.171 , pp. 571-582
    • Schenk, J.M.1    Kristal, A.R.2    Neuhouser, M.L.3    Tangen, C.M.4    White, E.5    Lin, D.W.6
  • 29
    • 0036604284 scopus 로고    scopus 로고
    • Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation
    • Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, et al. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 2002;52:43-58.
    • (2002) Prostate , vol.52 , pp. 43-58
    • Kramer, G.1    Steiner, G.E.2    Handisurya, A.3    Stix, U.4    Haitel, A.5    Knerer, B.6
  • 30
    • 40849105413 scopus 로고    scopus 로고
    • Chronic inflammation in benign prostatic hyperplasia: Implications for therapy
    • Wang L, Yang JR, Yang LY, Liu ZT. Chronic inflammation in benign prostatic hyperplasia: implications for therapy. Med Hypotheses 2008;70:1021-3.
    • (2008) Med Hypotheses , vol.70 , pp. 1021-1023
    • Wang, L.1    Yang, J.R.2    Yang, L.Y.3    Liu, Z.T.4
  • 31
    • 29944444331 scopus 로고    scopus 로고
    • Could inflammation be a key component in the progression of benign prostatic hyperplasia?
    • Kramer G, Marberger M. Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr opin Uro 2006;16:25-9.
    • (2006) Curr Opin Uro , vol.16 , pp. 25-29
    • Kramer, G.1    Marberger, M.2
  • 32
    • 64249163290 scopus 로고    scopus 로고
    • Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation
    • Penna G, Fibbi B, Amuchastegui S, Cossetti C, Aquilano F, Laverny G, et al. Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation. J Immunol 2009;182:4056-64.
    • (2009) J Immunol , vol.182 , pp. 4056-4064
    • Penna, G.1    Fibbi, B.2    Amuchastegui, S.3    Cossetti, C.4    Aquilano, F.5    Laverny, G.6
  • 33
    • 0029690257 scopus 로고    scopus 로고
    • Role of androgen in prostate growth and regression: Stromal-epithelial interaction
    • Lee C. Role of androgen in prostate growth and regression: stromal-epithelial interaction. Prostate Suppl 1996;6:52-6.
    • (1996) Prostate , vol.6 , Issue.SUPPL. , pp. 52-56
    • Lee, C.1
  • 34
    • 0032856169 scopus 로고    scopus 로고
    • Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFbeta)
    • Klingler HC, Bretland AJ, Reid SV, Chapple CR, Eaton CL. Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFbeta). Prostate 1999;41:110-20.
    • (1999) Prostate , vol.41 , pp. 110-120
    • Klingler, H.C.1    Bretland, A.J.2    Reid, S.V.3    Chapple, C.R.4    Eaton, C.L.5
  • 35
    • 8344242217 scopus 로고    scopus 로고
    • How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    • Zeegers MP, Kiemeney LA, Nieder AM, Ostrer H. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 2004;13:1765-71.
    • (2004) Cancer Epidemiol Biomarkers Prev , vol.13 , pp. 1765-1771
    • Zeegers, M.P.1    Kiemeney, L.A.2    Nieder, A.M.3    Ostrer, H.4
  • 36
    • 0142212410 scopus 로고    scopus 로고
    • The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer
    • Chatterjee B. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol Cell Biochem 2003;253:89-101.
    • (2003) Mol Cell Biochem , vol.253 , pp. 89-101
    • Chatterjee, B.1
  • 37
    • 0033119562 scopus 로고    scopus 로고
    • CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians
    • Giovannucci E, Stampfer MJ, Chan A, Krithivas K, Gann PH, Hennekens CH, et al. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians. Prostate 1999;39:130-4.
    • (1999) Prostate , vol.39 , pp. 130-134
    • Giovannucci, E.1    Stampfer, M.J.2    Chan, A.3    Krithivas, K.4    Gann, P.H.5    Hennekens, C.H.6
  • 39
    • 48149109454 scopus 로고    scopus 로고
    • Epidemiology of benign prostatic hyperplasia and comorbidities in racial and ethnic minority populations
    • Hoke GP, McWilliams GW. Epidemiology of benign prostatic hyperplasia and comorbidities in racial and ethnic minority populations. Am J Med 2008;121(8 Suppl 2):S3-10.
    • (2008) Am J Med , vol.121 , Issue.8 SUPPL. 2
    • Hoke, G.P.1    McWilliams, G.W.2
  • 40
    • 39849096422 scopus 로고    scopus 로고
    • Alpha1-adrenoceptor subtypes and lower urinary tract symptoms
    • Schwinn DA, Roehrborn CG. Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol 2008;15:193-9.
    • (2008) Int J Urol , vol.15 , pp. 193-199
    • Schwinn, D.A.1    Roehrborn, C.G.2
  • 41
    • 0033927006 scopus 로고    scopus 로고
    • Tissue selectivity of an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature
    • Murata S, Taniguchi T, Takahashi M, Okada K, Akiyama K, Muramatsu I. Tissue selectivity of an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature. J Urol 2000;164: 578-83.
    • (2000) J Urol , vol.164 , pp. 578-583
    • Murata, S.1    Taniguchi, T.2    Takahashi, M.3    Okada, K.4    Akiyama, K.5    Muramatsu, I.6
  • 42
    • 0031853559 scopus 로고    scopus 로고
    • Current status of research on prostate-selective alpha 1-antagonists
    • Kawabe K. Current status of research on prostate-selective alpha 1-antagonists. Br J Urol 1998;81(Suppl 1):48-50.
    • (1998) Br J Urol , vol.81 , Issue.1 SUPPL. , pp. 48-50
    • Kawabe, K.1
  • 43
    • 0034797955 scopus 로고    scopus 로고
    • The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms
    • Schwinn DA. The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms. BJU Int 2001;88(Suppl 2):27-34.
    • (2001) BJU Int , vol.88 , Issue.2 SUPPL. , pp. 27-34
    • Schwinn, D.A.1
  • 44
    • 48249138056 scopus 로고    scopus 로고
    • Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: Issues and potential complications
    • Fine SR, Ginsberg P. Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications. J Am Osteopath Assoc 2008;108:333-7.
    • (2008) J Am Osteopath Assoc , vol.108 , pp. 333-337
    • Fine, S.R.1    Ginsberg, P.2
  • 45
    • 0029155804 scopus 로고
    • KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: Characterization using recombinant human alpha 1-adrenoceptors and native tissues
    • Shibata K, Foglar R, Horie K, Obika K, Sakamoto A, Ogawa S, et al. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol Pharmacol 1995;48: 250-8.
    • (1995) Mol Pharmacol , vol.48 , pp. 250-258
    • Shibata, K.1    Foglar, R.2    Horie, K.3    Obika, K.4    Sakamoto, A.5    Ogawa, S.6
  • 46
    • 33749572713 scopus 로고    scopus 로고
    • Silodosin; Silodosin Clinical Study Group. A new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: Results of a phase III randomized, placebo-controlled, double-blind study in Japanese men
    • Kawabe K, Yoshida M, Homma Y. Silodosin; Silodosin Clinical Study Group. A new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU Int 2006;98:1019-24.
    • (2006) BJU Int , vol.98 , pp. 1019-1024
    • Kawabe, K.1    Yoshida, M.2    Homma, Y.3
  • 47
    • 51349132022 scopus 로고    scopus 로고
    • Inhibition of Seminal emission is the main cause of aneja-culation induced by a new highly selective alpha1A-blocker in normal volunteers
    • Kobayashi K, Masumori N, Hisasue S, Kato R, Hashimoto K, Itoh N, et al. Inhibition of Seminal emission is the main cause of aneja-culation induced by a new highly selective alpha1A-blocker in normal volunteers. J Sex Med 2008;5:2185-90.
    • (2008) J Sex Med , vol.5 , pp. 2185-2190
    • Kobayashi, K.1    Masumori, N.2    Hisasue, S.3    Kato, R.4    Hashimoto, K.5    Itoh, N.6
  • 48
    • 34848818085 scopus 로고    scopus 로고
    • Alpha1-adrenoceptors and ejaculatory function
    • Michel MC. Alpha1-adrenoceptors and ejaculatory function. Br J Pharmacol 2007;152:289-90.
    • (2007) Br J Pharmacol , vol.152 , pp. 289-290
    • Michel, M.C.1
  • 49
    • 0032587629 scopus 로고    scopus 로고
    • Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective in-hibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors
    • Takei R, Ikegaki I, Shibata K, Tsujimoto G, Asano T. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective in-hibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 1999;79: 447-54.
    • (1999) Jpn J Pharmacol , vol.79 , pp. 447-454
    • Takei, R.1    Ikegaki, I.2    Shibata, K.3    Tsujimoto, G.4    Asano, T.5
  • 50
    • 0344736941 scopus 로고    scopus 로고
    • Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: A comparative, randomized, two-drug crossover study
    • Ikemoto I, Kiyota H, Ohishi Y, Abe K, Goto H, Kishimoto K, et al. Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study. Int J Uro 2003;10:587-94.
    • (2003) Int J Uro , vol.10 , pp. 587-594
    • Ikemoto, I.1    Kiyota, H.2    Ohishi, Y.3    Abe, K.4    Goto, H.5    Kishimoto, K.6
  • 51
    • 33644897341 scopus 로고    scopus 로고
    • Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: A randomized crossover study
    • Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int 2006;97:747-51.
    • (2006) BJU Int , vol.97 , pp. 747-751
    • Nishino, Y.1    Masue, T.2    Miwa, K.3    Takahashi, Y.4    Ishihara, S.5    Deguchi, T.6
  • 52
    • 0026503988 scopus 로고
    • Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia
    • McConnell JD, Wilson JD, George FW, Geller J, Pappas F, Stoner E. Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab 1992;74:505-8.
    • (1992) J Clin Endocrinol Metab , vol.74 , pp. 505-508
    • McConnell, J.D.1    Wilson, J.D.2    George, F.W.3    Geller, J.4    Pappas, F.5    Stoner, E.6
  • 53
    • 34249989027 scopus 로고    scopus 로고
    • The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia
    • Wurzel R, Ray P, Major-Walker K, Shannon J, Rittmaster R. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2007;10:149-54.
    • (2007) Prostate Cancer Prostatic Dis , vol.10 , pp. 149-154
    • Wurzel, R.1    Ray, P.2    Major-Walker, K.3    Shannon, J.4    Rittmaster, R.5
  • 54
    • 0347882750 scopus 로고    scopus 로고
    • The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
    • McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J 2003;349:2387-98.
    • (2003) N Engl J , vol.349 , pp. 2387-2398
    • McConnell, J.D.1    Roehrborn, C.G.2    Bautista, O.M.3    Andriole, G.L.4    Dixon, C.M.5    Kusek, J.W.6
  • 55
    • 70449536472 scopus 로고    scopus 로고
    • The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study
    • Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol 2010;57:123-31.
    • (2010) Eur Urol , vol.57 , pp. 123-131
    • Roehrborn, C.G.1    Siami, P.2    Barkin, J.3    Damião, R.4    Major-Walker, K.5    Nandy, I.6
  • 56
    • 34548795965 scopus 로고    scopus 로고
    • Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia
    • Kang KK, Kim JM, Yu JY, Ahn BO, Yoo M, Kim YC. Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia. Int J Urol 2007;14:946-51.
    • (2007) Int J Urol , vol.14 , pp. 946-951
    • Kang, K.K.1    Kim, J.M.2    Yu, J.Y.3    Ahn, B.O.4    Yoo, M.5    Kim, Y.C.6
  • 57
    • 34548815922 scopus 로고    scopus 로고
    • GMP-enhancing and alpha1A/alpha1D-adrenoceptor block-ade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy
    • Liu CM, Lo YC, Wu BN, Wu WJ, Chou YH, Huang CH, et al.GMP-enhancing and alpha1A/alpha1D-adrenoceptor block-ade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy. Prostate 2007;67:1397-410.
    • (2007) Prostate , vol.67 , pp. 1397-1410
    • Liu, C.M.1    Lo, Y.C.2    Wu, B.N.3    Wu, W.J.4    Chou, Y.H.5    Huang, C.H.6
  • 58
    • 0242608409 scopus 로고    scopus 로고
    • Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adre-nergic contraction of prostatic smooth muscle cells
    • Rees RW, Foxwell NA, Ralph DJ, Kell PD, Moncada S, Cellek S. Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adre-nergic contraction of prostatic smooth muscle cells. J Urol 2003;170:2517-22.
    • (2003) J Urol , vol.170 , pp. 2517-2522
    • Rees, R.W.1    Foxwell, N.A.2    Ralph, D.J.3    Kell, P.D.4    Moncada, S.5    Cellek, S.6
  • 59
    • 9644272419 scopus 로고    scopus 로고
    • GMP-generating cells in the bladder wall: Identification of distinct net-works of interstitial cells
    • Gillespie JI, Markerink-van Ittersum M, de Vente J. GMP-generating cells in the bladder wall: identification of distinct net-works of interstitial cells. BJU Int 2004;94:1114-24.
    • (2004) BJU Int , vol.94 , pp. 1114-1124
    • Gillespie, J.I.1    Markerink-Vanittersum, M.2    de Vente, J.3
  • 61
    • 0038507051 scopus 로고    scopus 로고
    • Chronic is-chemia increases prostatic smooth muscle contraction in the rabbit
    • Azadzoi KM, Babayan RK, Kozlowski R, Siroky MB. Chronic is-chemia increases prostatic smooth muscle contraction in the rabbit. J Urol 2003;170:659-63.
    • (2003) J Urol , vol.170 , pp. 659-663
    • Azadzoi, K.M.1    Babayan, R.K.2    Kozlowski, R.3    Siroky, M.B.4
  • 62
    • 33846810223 scopus 로고    scopus 로고
    • Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized, double-blind trial
    • McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 2007;177:1071-7.
    • (2007) J Urol , vol.177 , pp. 1071-1077
    • McVary, K.T.1    Monnig, W.2    Camps Jr., J.L.3    Young, J.M.4    Tseng, L.J.5    van den Ende, G.6
  • 63
    • 50949119951 scopus 로고    scopus 로고
    • Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A dose finding study
    • Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. J Urol 2008;180:1228-34.
    • (2008) J Urol , vol.180 , pp. 1228-1234
    • Roehrborn, C.G.1    McVary, K.T.2    Elion-Mboussa, A.3    Viktrup, L.4
  • 64
    • 42749084255 scopus 로고    scopus 로고
    • A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    • Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008;53:1236-44.
    • (2008) Eur Urol , vol.53 , pp. 1236-1244
    • Stief, C.G.1    Porst, H.2    Neuser, D.3    Beneke, M.4    Ulbrich, E.5
  • 65
    • 3042576191 scopus 로고    scopus 로고
    • Complementary and alternative medicine use among adults: United States, 2002
    • Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv data 2004;(343):1-19.
    • (2004) Adv Data , Issue.343 , pp. 1-19
    • Barnes, P.M.1    Powell-Griner, E.2    McFann, K.3    Nahin, R.L.4
  • 67
    • 43049131416 scopus 로고    scopus 로고
    • Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia
    • Dedhia RC, McVary KT. Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2008;179:2119-25.
    • (2008) J Urol , vol.179 , pp. 2119-2125
    • Dedhia, R.C.1    McVary, K.T.2
  • 68
    • 5444256882 scopus 로고    scopus 로고
    • Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action
    • Buck AC. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action. J Urol 2004;172:1792-9.
    • (2004) J Urol , vol.172 , pp. 1792-1799
    • Buck, A.C.1
  • 69
    • 0026469615 scopus 로고
    • Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients
    • Di Silverio F, D'Eramo G, Lubrano C, Flammia GP, Sciarra A, Palma E, et al. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol 1992;21:309-14.
    • (1992) Eur Urol , vol.21 , pp. 309-314
    • di Silverio, F.1    D'eramo, G.2    Lubrano, C.3    Flammia, G.P.4    Sciarra, A.5    Palma, E.6
  • 70
    • 0033763902 scopus 로고    scopus 로고
    • Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasia
    • Vacherot F, Azzouz M, Gil-Diez-De-Medina S, Colombel M, De La Taille A, Lefrère Belda MA, et al. Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasia. Prostate 2000;45:259-66.
    • (2000) Prostate , vol.45 , pp. 259-266
    • Vacherot, F.1    Azzouz M.Gil-Diez-De-Medina, S.2    Colombel, M.3    de la Taille, A.4    Lefrère, B.M.A.5
  • 71
    • 80053219508 scopus 로고    scopus 로고
    • Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: A randomized trial
    • Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, et al. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA 2011;306:1344-51.
    • (2011) JAMA , vol.306 , pp. 1344-1351
    • Barry, M.J.1    Meleth, S.2    Lee, J.Y.3    Kreder, K.J.4    Avins, A.L.5    Nickel, J.C.6
  • 72
    • 79959813899 scopus 로고    scopus 로고
    • Current status of transurethral prostatectomy: A Korean multicenter study
    • Jang DG, Yoo C, Oh CY, Kim SJ, Kim SI, Kim CI, et al. Current status of transurethral prostatectomy: a Korean multicenter study. Korean J Urol 2011;52:406-9.
    • (2011) Korean J Urol , vol.52 , pp. 406-409
    • Jang, D.G.1    Yoo, C.2    Oh, C.Y.3    Kim, S.J.4    Kim, S.I.5    Kim, C.I.6
  • 73
    • 77952753507 scopus 로고    scopus 로고
    • The role of TURP in the detection of prostate cancer in BPH patients with previously negative prostate biopsy
    • Kim DK, Kim SJ, Moon HS, Park SY, Kim YT, Choi HY, et al. The role of TURP in the detection of prostate cancer in BPH patients with previously negative prostate biopsy. Korean J Urol 2010;51: 313-7.
    • (2010) Korean J Urol , vol.51 , pp. 313-317
    • Kim, D.K.1    Kim, S.J.2    Moon, H.S.3    Park, S.Y.4    Kim, Y.T.5    Choi, H.Y.6
  • 74
    • 84859013340 scopus 로고    scopus 로고
    • Survival after incidental prostate cancer diagnosis at transurethral resection of prostate: 10-year outcomes
    • Ahmad S, O'Kelly F, Manecksha RP, Cullen IM, Flynn RJ, McDermott TE, et al. Survival after incidental prostate cancer diagnosis at transurethral resection of prostate: 10-year outcomes. Ir J Med Sci 2012;181:27-31.
    • (2012) Ir J Med Sci , vol.181 , pp. 27-31
    • Ahmad, S.1    O'Kelly, F.2    Manecksha, R.P.3    Cullen, I.M.4    Flynn, R.J.5    McDermott, T.E.6
  • 75
    • 68549115466 scopus 로고    scopus 로고
    • Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms
    • van Renterghem K, van Koeveringe G, Achten R, van Kerrebroeck P. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms. Urol Int 2009;83:60-5.
    • (2009) Urol Int , vol.83 , pp. 60-65
    • van Renterghem, K.1    van Koeveringe, G.2    Achten, R.3    van Kerrebroeck, P.4
  • 76
    • 0036136520 scopus 로고    scopus 로고
    • Writing Committee. The American Urlogical Association. Transurethral prostatectomy: Immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients
    • J Urol, 141:243-247, 1989
    • Mebust WK, Holtgrewe HL, Cockett AT, Peters PC; Writing Committee. The American Urlogical Association. Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol, 141:243-247, 1989. J Urol 2002;167:5-9.
    • (2002) J Urol , vol.167 , pp. 5-9
    • Mebust, W.K.1    Holtgrewe, H.L.2    Cockett, A.T.3    Peters, P.C.4
  • 77
    • 0032840725 scopus 로고    scopus 로고
    • Immediate and postoperative complications of transurethral prostatectomy in the 1990s
    • Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999;162:1307-10.
    • (1999) J Urol , vol.162 , pp. 1307-1310
    • Borboroglu, P.G.1    Kane, C.J.2    Ward, J.F.3    Roberts, J.L.4    Sands, J.P.5
  • 78
    • 46549087605 scopus 로고    scopus 로고
    • Morbidity, mortality and early outcome of transurethral resection of the prostate: A prospective multicenter evaluation of 10,654 patients
    • Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008;180:246-9.
    • (2008) J Urol , vol.180 , pp. 246-249
    • Reich, O.1    Gratzke, C.2    Bachmann, A.3    Seitz, M.4    Schlenker, B.5    Hermanek, P.6
  • 79
    • 58149277202 scopus 로고    scopus 로고
    • The efficacy of bipolar transurethral resection of the prostate in patients with large prostates (>80 g) and analysis of the postoperative results based on the resection ratio
    • Baek M, Paick SH, Lee BK, Kang MB, Lho YS, Jung SI, et al. The efficacy of bipolar transurethral resection of the prostate in patients with large prostates (>80 g) and analysis of the postoperative results based on the resection ratio. Korean J Urol 2008;49:1087-93.
    • (2008) Korean J Urol , vol.49 , pp. 1087-1093
    • Baek, M.1    Paick, S.H.2    Lee, B.K.3    Kang, M.B.4    Lho, Y.S.5    Jung, S.I.6
  • 80
    • 33750688491 scopus 로고    scopus 로고
    • Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: One-year outcome
    • Yoon CJ, Kim JY, Moon KH, Jung HC, Park TC. Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: one-year outcome. Yonsei Med J 2006;47:715-20.
    • (2006) Yonsei Med J , vol.47 , pp. 715-720
    • Yoon, C.J.1    Kim, J.Y.2    Moon, K.H.3    Jung, H.C.4    Park, T.C.5
  • 81
    • 0036093513 scopus 로고    scopus 로고
    • Laparoscopic prostatectomy with vascular control for benign prostatic hyperplasia
    • Mariano MB, Graziottin TM, Tefilli MV. Laparoscopic prostatectomy with vascular control for benign prostatic hyperplasia. J Urol 2002;167:2528-9.
    • (2002) J Urol , vol.167 , pp. 2528-2529
    • Mariano, M.B.1    Graziottin, T.M.2    Tefilli, M.V.3
  • 82
    • 33645990898 scopus 로고    scopus 로고
    • Laparoscopic versus open simple prostatectomy: A comparative study
    • Baumert H, Ballaro A, Dugardin F, Kaisary AV. Laparoscopic versus open simple prostatectomy: a comparative study. J Urol 2006;175:1691-4.
    • (2006) J Urol , vol.175 , pp. 1691-1694
    • Baumert, H.1    Ballaro, A.2    Dugardin, F.3    Kaisary, A.V.4
  • 83
    • 77952757514 scopus 로고    scopus 로고
    • Early experience with laparoscopic retropubic simple prostatectomy in patients with voluminous benign prostatic hyperplasia (BPH)
    • Yun HK, Kwon JB, Cho SR, Kim JS. Early experience with laparoscopic retropubic simple prostatectomy in patients with voluminous benign prostatic hyperplasia (BPH). Korean J Urol 2010;51: 323-9.
    • (2010) Korean J Urol , vol.51 , pp. 323-329
    • Yun, H.K.1    Kwon, J.B.2    Cho, S.R.3    Kim, J.S.4
  • 84
    • 44649198604 scopus 로고    scopus 로고
    • Initial experience of laparoscopic simple prostatectomy in patients with large benign prostatic hyperplasia
    • Kim BH, Ryu DS, Oh TH. Initial experience of laparoscopic simple prostatectomy in patients with large benign prostatic hyperplasia. Korean J Urol 2008;49:418-23.
    • (2008) Korean J Urol , vol.49 , pp. 418-423
    • Kim, B.H.1    Ryu, D.S.2    Oh, T.H.3
  • 85
    • 79955680691 scopus 로고    scopus 로고
    • Long-term follow-up results of photoselective vaporization of the prostate with the 120 W Greenlight HPS laser for treatment of benign prostatic hyperplasia
    • Kang SH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, et al. Long-term follow-up results of photoselective vaporization of the prostate with the 120 W Greenlight HPS laser for treatment of benign prostatic hyperplasia. Korean J Urol 2011;52:260-4.
    • (2011) Korean J Urol , vol.52 , pp. 260-264
    • Kang, S.H.1    Choi, Y.S.2    Kim, S.J.3    Cho, H.J.4    Hong, S.H.5    Lee, J.Y.6
  • 86
    • 77952776314 scopus 로고    scopus 로고
    • The efficacy and safety of photoselective vaporization of the prostate with a potassium-titanyl-phosphate laser for symptomatic benign prostatic hyperplasia according to prostate size: 2-year surgical outcomes
    • Kim HS, Cho MC, Ku JH, Kim SW, Paick JS. The efficacy and safety of photoselective vaporization of the prostate with a potassium-titanyl-phosphate laser for symptomatic benign prostatic hyperplasia according to prostate size: 2-year surgical outcomes. Korean J Urol 2010;51:330-6.
    • (2010) Korean J Urol , vol.51 , pp. 330-336
    • Kim, H.S.1    Cho, M.C.2    Ku, J.H.3    Kim, S.W.4    Paick, J.S.5
  • 87
    • 77950114746 scopus 로고    scopus 로고
    • Holmium laser enucleation of the prostate for prostates larger than 175 grams
    • Krambeck AE, Handa SE, Lingeman JE. Holmium laser enucleation of the prostate for prostates larger than 175 grams. J Endourol 2010;24:433-7.
    • (2010) J Endourol , vol.24 , pp. 433-437
    • Krambeck, A.E.1    Handa, S.E.2    Lingeman, J.E.3
  • 88
    • 77956899469 scopus 로고    scopus 로고
    • Holmium laser enucleation of the prostate for benign prostatic hyperplasia: Effectiveness, safety, and overcoming of the learning curve
    • Hwang JC, Park SM, Lee JB. Holmium laser enucleation of the prostate for benign prostatic hyperplasia: effectiveness, safety, and overcoming of the learning curve. Korean J Urol 2010;51: 619-24.
    • (2010) Korean J Urol , vol.51 , pp. 619-624
    • Hwang, J.C.1    Park, S.M.2    Lee, J.B.3
  • 89
    • 41849083476 scopus 로고    scopus 로고
    • Holmium laser enucleation versus transurethral resection of the prostate: Results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia
    • Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation versus transurethral resection of the prostate: Results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2008;179(5 Suppl):S87-90.
    • (2008) J Urol , vol.179 , Issue.5 SUPPL
    • Montorsi, F.1    Naspro, R.2    Salonia, A.3    Suardi, N.4    Briganti, A.5    Zanoni, M.6
  • 90
    • 0141919740 scopus 로고    scopus 로고
    • Holmium laser enucleation for prostatic adenoma: Analysis of learning curve over the course of 70 consecutive cases
    • Seki N, Mochida O, Kinukawa N, Sagiyama K, Naito S. Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol 2003;170: 1847-50.
    • (2003) J Urol , vol.170 , pp. 1847-1850
    • Seki, N.1    Mochida, O.2    Kinukawa, N.3    Sagiyama, K.4    Naito, S.5
  • 91
    • 1842842069 scopus 로고    scopus 로고
    • Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size?
    • Kuntz RM, Lehrich K, Ahyai S. Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size? J Endourol 2004;18:183-8.
    • (2004) J Endourol , vol.18 , pp. 183-188
    • Kuntz, R.M.1    Lehrich, K.2    Ahyai, S.3
  • 92
    • 0036884199 scopus 로고    scopus 로고
    • Holmium laser enucleation of the prostate can be taught: The first learning experience
    • El-Hakim A, Elhilali MM. Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 2002;90:863-9.
    • (2002) BJU Int , vol.90 , pp. 863-869
    • El-Hakim, A.1    Elhilali, M.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.